Cite

HARVARD Citation

    Ikonomidis, I. et al. (n.d.). Four-months treatment with dapagliflozin improves endothelial glycocalyx and cardiovascular function in patients with type 1 diabetes mellitus. European heart journal. p. . [Online]. 
  
Back to record